His primary areas of investigation include Pathology, Alzheimer's disease, Dementia, Positron emission tomography and Amyloid. As a part of the same scientific study, Timo Grimmer usually deals with the Pathology, concentrating on Central nervous system disease and frequently concerns with Cerebrospinal fluid. His Alzheimer's disease study improves the overall literature in Internal medicine.
His Dementia study is mostly concerned with Clinical Dementia Rating and Cognitive disorder. His Positron emission tomography research is multidisciplinary, incorporating perspectives in Prospective cohort study and Magnetic resonance imaging. As part of the same scientific family, he usually focuses on Amyloid deposition, concentrating on Control subjects and intersecting with Disease.
The scientist’s investigation covers issues in Dementia, Disease, Pathology, Internal medicine and Alzheimer's disease. His Dementia research focuses on subjects like Degenerative disease, which are linked to Cognitive disorder. His Disease research incorporates themes from Cerebrospinal fluid and Neuroscience.
Timo Grimmer works mostly in the field of Pathology, limiting it down to topics relating to Positron emission tomography and, in certain cases, Magnetic resonance imaging, as a part of the same area of interest. His Internal medicine research integrates issues from Oncology and Cardiology. The study incorporates disciplines such as Central nervous system disease, Audiology, Psychiatry, Cognition and Atrophy in addition to Alzheimer's disease.
His main research concerns Disease, Dementia, Internal medicine, Biomarker and Pathology. His Disease research incorporates elements of Positron emission tomography, Neuroimaging, Neuroscience and Blood marker. His Dementia study incorporates themes from Odds ratio, Case-control study, Attributable risk, Alzheimer's disease and Apolipoprotein E.
His biological study spans a wide range of topics, including Ophthalmology and Functional decline, Gerontology. His research in Internal medicine intersects with topics in Endocrinology and Oncology. Pathology is frequently linked to Concordance in his study.
Timo Grimmer spends much of his time researching Internal medicine, Dementia, Disease, Frontotemporal dementia and Biomarker. Timo Grimmer has included themes like Gastroenterology and Cognition in his Internal medicine study. The various areas that he examines in his Dementia study include Augmented reality, Genetic association, Bioinformatics and Amyloid.
His Disease study is concerned with the larger field of Pathology. His Pathology study integrates concerns from other disciplines, such as Cerebellum, Positron emission tomography, Mutation and Thalamus. The Frontotemporal dementia study combines topics in areas such as Alzheimer's disease, Differential diagnosis, Imaging modalities and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mapping scores onto stages: mini-mental state examination and clinical dementia rating.
Robert Perneczky;Stefan Wagenpfeil;Katja Komossa;Timo Grimmer.
American Journal of Geriatric Psychiatry (2006)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Alexander Drzezga;Timo Grimmer;Matthias Riemenschneider;Nicola Lautenschlager.
The Journal of Nuclear Medicine (2005)
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Timo Grimmer;Matthias Riemenschneider;Hans Förstl;Gjermund Henriksen.
Biological Psychiatry (2009)
Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome
Robert Perneczky;Corina Pohl;Christian Sorg;Julia Hartmann.
International Journal of Geriatric Psychiatry (2006)
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
A. Drzezga;T. Grimmer;G. Henriksen;M. Mühlau.
Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.
J Diehl;T Grimmer;A Drzezga;M Riemenschneider.
Neurobiology of Aging (2004)
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.
J. Diehl-Schmid;T. Grimmer;A. Drzezga;S. Bornschein.
Neurobiology of Aging (2007)
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
Alexander Drzezga;Timo Grimmer;Gjermund Henriksen;Isabelle Stangier.
Progression to dementia in clinical subtypes of mild cognitive impairment.
P. Alexopoulos;T. Grimmer;R. Perneczky;G. Domes.
Dementia and Geriatric Cognitive Disorders (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: